MAPT and Alzheimer disease: Since for ‘typical’ AD we can expect a decreased plasma Aβ42/40 ratio and elevated p-tau181 and p-tau21726, observing elevated p-tau in RHI-exposed individuals without a decreased Aβ42/40 ratio might hint more towards underlying CTE-pathology than AD-pathology only.